Aromatase inhibitor treatment for breast cancer: short-term effect on bone health

about

Aromatase inhibitor treatment for breast cancer: short-term effect on bone health

Item

http://www.wikidata.org/entity/Q36452858

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Aromatase inhibitor treatment for breast cancer: short-term effect on bone health

@ast

Aromatase inhibitor treatment for breast cancer: short-term effect on bone health

@en

type

Item

label

Aromatase inhibitor treatment for breast cancer: short-term effect on bone health

@ast

Aromatase inhibitor treatment for breast cancer: short-term effect on bone health

@en

prefLabel

Aromatase inhibitor treatment for breast cancer: short-term effect on bone health

@ast

Aromatase inhibitor treatment for breast cancer: short-term effect on bone health

@en

P1476

Aromatase inhibitor treatment for breast cancer: short-term effect on bone health

@en

P2093

Ayşe Nurdan Korkmaz

http://www.w3.org/2001/XMLSchema#string

Emine Binnetoğlu

http://www.w3.org/2001/XMLSchema#string

Fahri Güneş

http://www.w3.org/2001/XMLSchema#string

Ferhat Gökmen

http://www.w3.org/2001/XMLSchema#string

Gökhan Erbağ

http://www.w3.org/2001/XMLSchema#string

Hacer Şen

http://www.w3.org/2001/XMLSchema#string

Kazım Uygun

http://www.w3.org/2001/XMLSchema#string

Mehmet Aşık

http://www.w3.org/2001/XMLSchema#string

Mustafa Eroğlu

http://www.w3.org/2001/XMLSchema#string

Süleyman Temiz

http://www.w3.org/2001/XMLSchema#string

P2860

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

Cancer statistics, 2006

Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue.

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

Multifactorial analysis of risk factors for reduced bone mineral density among postmenopausal women

Long-term effects of aromatase inhibitors on bone.

Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment.

Endocrine effects of nonsteroidal aromatase inhibitors and their clinical impact.

Long-term effects of anastrozole on bone mineral density: 7-year results from the ATAC trial.

Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.

P304

374-377

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/WO.2014.45305

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26793021

http://www.w3.org/2001/XMLSchema#string

P932

4709393

http://www.w3.org/2001/XMLSchema#string